Mass Cytometry Moving Forward in Support of Clinical Research: Advantages and Considerations

10.1002/0471722731

10.1126/science.1198704

10.1021/ac901049w

10.1186/s13059-014-0525-9

10.1016/j.stemcr.2014.11.003

10.1016/j.stemcr.2013.07.005

10.1126/science.1250689

10.1016/j.neuron.2014.10.016

10.1093/nar/gku555

10.1016/j.drudis.2015.06.001

10.1002/1099-0801(200010)14:6<422::AID-BMC25>3.0.CO;2-I

Nassar AE , TalaatRE, KamelAM. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?Curr. Opin. Drug Discov. Devel. 9 (1), 61–74 (2006).

10.1038/nbt.2317

10.1038/nprot.2015.020

10.1002/cyto.a.22640

10.1021/bm201011t

10.4049/jimmunol.1402661

Nassar AE , CarterB, LanniganJet al. The first multi-center comparative study using a novel technology mass cytometry Time-of-Flight mass spectrometer (CyTOF2) for high-speed acquisition of highly multi-parametric single cell data: a status report. Presented at : CYTO 2015 30th Congress of the International Society for Advancement of Cytometry. Scottish Exhibition and Conference Centre Glasgow, UK, 26 –30 June 2015.

10.1016/j.jim.2014.10.010